advertisement

Meds and you

24 June 2011

Glaxo to pay $41mil for drug quality

British pharmaceutical giant GlaxoSmithKline said it is paying $41 million (about R278 million) to settle allegations of poor drug quality at a manufacturing plant in Puerto Rico.

British pharmaceutical giant GlaxoSmithKline said it is paying $41 million (about R278 million) to settle allegations of poor drug quality at a manufacturing plant in Puerto Rico.

GlaxoSmithKline rejected the accusations and said there was no evidence that patients had been harmed.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.